Pseudomonas Aeruginosa Antibody Response in Cystic Fibrosis Decreases Rapidly Following Lung Transplantation
Infection Prevention and Control in Patients With Cystic Fibrosis (CF): Results From a Survey in 35 German CF Treatment Centers
A Study to Test the Effects of a Treatment Called Amikacin Liposome Inhalation Suspension on Chronic Pseudomonas aeruginosa Infection in People with Cystic Fibrosis
Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young U.S. children with cystic fibrosis.
A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with Cystic Fibrosis for application in clinical trials
